Literature DB >> 28420945

Controversies and Recent Developments of the Low-FODMAP Diet.

Peta Hill1, Jane G Muir1, Peter R Gibson1.   

Abstract

The low-fermentable oligo-, di-, and monosaccharide and polyol (FODMAP) diet is a 2-phased intervention, with strict reduction of all slowly absorbed or indigestible short-chain carbohydrates (ie, FODMAPs) followed by reintroduction of specific FODMAPs according to tolerance. The efficacy of the elimination phase of the FODMAP diet is well established, but the success of maintaining this diet has been shown in only a few observational studies. How the efficacy of the low-FODMAP diet compares with that of other therapies has received limited attention, but recent studies have shown this diet to be comparable or superior to diets that address eating style and choice of food as well as to gut hypnotherapy. There has been no comparison between the low-FODMAP diet and the gluten-free diet, which moderately reduces FODMAP intake. Mechanistically, dietary FODMAPs have very limited effects on the consistency of bowel actions but seem to suppress the release of histamine. Neither symptom pattern nor breath hydrogen testing for fructose or polyol malabsorption is a useful predictor of efficacy, but analysis of gut microbiota has potential. As a restrictive diet, the low-FODMAP diet carries risks of nutritional inadequacy and of fostering disordered eating, which has received little attention. Strict FODMAP restriction induces a potentially unfavorable gut microbiota, although the impact of this consequence upon health is unknown. This observation puts additional impetus on the reintroduction of FODMAPs according to tolerance during the maintenance phase of the diet. Studies of the low-FODMAP diet in children are few but do suggest benefit. However, such a strategy should be implemented with care due to the psychological and nutritional risks of a restrictive diet. Clinical wisdom is required in utilizing the low-FODMAP diet.

Entities:  

Keywords:  Irritable bowel syndrome; breath hydrogen testing; disordered eating; fructans; fructose; galacto-oligosaccharides; polyols

Year:  2017        PMID: 28420945      PMCID: PMC5390324     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  63 in total

1.  Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome.

Authors:  G C Parkes; N B Rayment; B N Hudspith; L Petrovska; M C Lomer; J Brostoff; K Whelan; J D Sanderson
Journal:  Neurogastroenterol Motil       Date:  2011-11-09       Impact factor: 3.598

2.  Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome.

Authors:  L Whigham; T Joyce; G Harper; P M Irving; H M Staudacher; K Whelan; M C E Lomer
Journal:  J Hum Nutr Diet       Date:  2015-04-14       Impact factor: 3.089

3.  Not all effects of a gluten-free diet are due to removal of gluten.

Authors:  Peter R Gibson; Jane G Muir
Journal:  Gastroenterology       Date:  2013-07-27       Impact factor: 22.682

4.  Poor reproducibility of breath hydrogen testing: Implications for its application in functional bowel disorders.

Authors:  Chu K Yao; Caroline J Tuck; Jacqueline S Barrett; Kim Ek Canale; Hamish L Philpott; Peter R Gibson
Journal:  United European Gastroenterol J       Date:  2016-07-07       Impact factor: 4.623

Review 5.  Review article: the aetiology, diagnosis, mechanisms and clinical evidence for food intolerance.

Authors:  M C E Lomer
Journal:  Aliment Pharmacol Ther       Date:  2014-12-03       Impact factor: 8.171

6.  A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function.

Authors:  Maria I Vazquez-Roque; Michael Camilleri; Thomas Smyrk; Joseph A Murray; Eric Marietta; Jessica O'Neill; Paula Carlson; Jesse Lamsam; Denise Janzow; Deborah Eckert; Duane Burton; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2013-01-25       Impact factor: 22.682

7.  Characterization of Adults With a Self-Diagnosis of Nonceliac Gluten Sensitivity.

Authors:  Jessica R Biesiekierski; Evan D Newnham; Susan J Shepherd; Jane G Muir; Peter R Gibson
Journal:  Nutr Clin Pract       Date:  2014-04-16       Impact factor: 3.080

8.  Fructose intolerance in children presenting with abdominal pain.

Authors:  Robert E Gomara; Michael S Halata; Leonard J Newman; Howard E Bostwick; Stuart H Berezin; Lynnette Cukaj; Mary C See; Marvin S Medow
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-09       Impact factor: 2.839

Review 9.  Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome.

Authors:  Caroline J Tuck; Jane G Muir; Jacqueline S Barrett; Peter R Gibson
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2014-05-15       Impact factor: 3.869

10.  Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome.

Authors:  R Laatikainen; J Koskenpato; S-M Hongisto; J Loponen; T Poussa; M Hillilä; R Korpela
Journal:  Aliment Pharmacol Ther       Date:  2016-07-15       Impact factor: 8.171

View more
  24 in total

1.  Is a low FODMAP diet dangerous?

Authors:  M Bellini; A Rossi
Journal:  Tech Coloproctol       Date:  2018-08-06       Impact factor: 3.781

2.  Changes in gut microbial metagenomic pathways associated with clinical outcomes after the elimination of malabsorbed sugars in an IBS cohort.

Authors:  A Mack; J S Bobardt; A Haß; K B Nichols; R M Schmid; C K Stein-Thoeringer
Journal:  Gut Microbes       Date:  2019-12-06

3.  Global Research Trends in Irritable Bowel Syndrome: A Bibliometric and Visualized Study.

Authors:  Tai Zhang; Xiangxue Ma; Wende Tian; Jiaqi Zhang; Yuchen Wei; Beihua Zhang; Fengyun Wang; Xudong Tang
Journal:  Front Med (Lausanne)       Date:  2022-06-27

4.  Gut Microbiota-Based Therapies for Irritable Bowel Syndrome.

Authors:  Emily K Stern; Darren M Brenner
Journal:  Clin Transl Gastroenterol       Date:  2018-02-15       Impact factor: 4.488

5.  FODMAP Intake in Spanish Population: Open Approach for Risk Assessment.

Authors:  Jonatan Miranda; Maialen Vázquez-Polo; Gesala Pérez-Junkera; María Del Pilar Fernández-Gil; María Ángeles Bustamante; Virginia Navarro; Edurne Simón; Olaia Martínez
Journal:  Int J Environ Res Public Health       Date:  2020-08-13       Impact factor: 3.390

Review 6.  Exit Gluten-Free and Enter Low FODMAPs: A Novel Dietary Strategy to Reduce Gastrointestinal Symptoms in Athletes.

Authors:  Dana M Lis
Journal:  Sports Med       Date:  2019-02       Impact factor: 11.136

7.  Dietary exclusion of fructose and lactose after positive breath tests improved rapid-transit constipation in children.

Authors:  Kasturi Waingankar; Christoper Lai; Vishal Punwani; Jeremy Wong; John M Hutson; Bridget R Southwell
Journal:  JGH Open       Date:  2018-08-14

Review 8.  Non-Celiac Gluten Sensitivity: An Update.

Authors:  Feliznando Isidro Cárdenas-Torres; Francisco Cabrera-Chávez; Oscar Gerardo Figueroa-Salcido; Noé Ontiveros
Journal:  Medicina (Kaunas)       Date:  2021-05-24       Impact factor: 2.430

9.  The Food-Specific Serum IgG Reactivity in Major Depressive Disorder Patients, Irritable Bowel Syndrome Patients and Healthy Controls.

Authors:  Hanna Karakula-Juchnowicz; Mirosława Gałęcka; Joanna Rog; Anna Bartnicka; Zuzanna Łukaszewicz; Pawel Krukow; Justyna Morylowska-Topolska; Karolina Skonieczna-Zydecka; Tomasz Krajka; Kamil Jonak; Dariusz Juchnowicz
Journal:  Nutrients       Date:  2018-04-28       Impact factor: 5.717

Review 10.  The nutritional and health attributes of kiwifruit: a review.

Authors:  David P Richardson; Juliet Ansell; Lynley N Drummond
Journal:  Eur J Nutr       Date:  2018-02-22       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.